Concepedia

Phuong K. Morrow

PK

Statistics

Publications

41

Citations

2.3K

H-Index

26

Active since

1979

Affiliations

Amgen (United States)(Current)

The University of Texas MD Anderson Cancer Center

University of Washington

Fred Hutch Cancer Center

Peter MacCallum Cancer Centre

Phuong K. Morrow is an author at Amgen (United States) specializing in medicine, oncology, and breast cancer.

Top concepts

Publications per year

1979–2024

41

Publications

41

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Haydar Frangoul, Franco Locatelli, Akshay Sharma et al. · New England Journal of Medicine · 2024 · 304 citations

Phase I/II Study of Trastuzumab in Combination With Everolimus (RAD001) in Patients With HER2-Overexpressing Metastatic Breast Cancer Who Progressed on Trastuzumab-Based Therapy

Phuong K. Morrow, Gerburg M. Wulf, Joe Ensor et al. · Journal of Clinical Oncology · 2011 · 211 citations · Full text

Phase 1 study evaluating the safety, tolerability, pharmacokinetics (PK), and efficacy of AMG 510, a novel small molecule <i>KRAS<sup>G12C</sup></i> inhibitor, in advanced solid tumors.

Marwan Fakih, Bert H. O’Neil, Timothy Price et al. · Journal of Clinical Oncology · 2019 · 172 citations

, , +18

Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

Franco Locatelli, Peter Lang, Donna A. Wall et al. · New England Journal of Medicine · 2024 · 144 citations

Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices

Neelima Denduluri, Debra A. Patt, Yunfei Wang et al. · Journal of the National Comprehensive Cancer Network · 2015 · 139 citations · Full text

1–5 of 41